Viridien
CGPVF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $267 | $234 | $258 | $427 |
| % Growth | 14.1% | -9% | -39.6% | – |
| Cost of Goods Sold | $160 | $190 | $171 | $284 |
| Gross Profit | $107 | $44 | $87 | $142 |
| % Margin | 40% | 18.9% | 33.6% | 33.4% |
| R&D Expenses | $2 | $3 | $4 | $3 |
| G&A Expenses | $0 | $20 | $18 | $27 |
| SG&A Expenses | $27 | $28 | $26 | $36 |
| Sales & Mktg Exp. | $0 | $9 | $8 | $9 |
| Other Operating Expenses | $0 | -$2 | $0 | $55 |
| Operating Expenses | $29 | $30 | $30 | $94 |
| Operating Income | $78 | $15 | $56 | $49 |
| % Margin | 29.2% | 6.3% | 21.9% | 11.5% |
| Other Income/Exp. Net | -$28 | -$16 | -$72 | -$21 |
| Pre-Tax Income | $50 | -$1 | -$16 | $28 |
| Tax Expense | $9 | -$6 | $13 | -$1 |
| Net Income | $41 | $6 | -$28 | $29 |
| % Margin | 15.4% | 2.3% | -10.8% | 6.7% |
| EPS | 5.71 | 0.77 | -3.89 | 3.99 |
| % Growth | 641.6% | 119.8% | -197.5% | – |
| EPS Diluted | 5.71 | 0.77 | -3.87 | 3.99 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $3 |
| Interest Expense | $28 | $29 | $28 | $26 |
| Depreciation & Amortization | $46 | $58 | $41 | $48 |
| EBITDA | $125 | $87 | $53 | $105 |
| % Margin | 46.7% | 37.1% | 20.7% | 24.6% |